# FDA Inspection 1235775 - Guangdong Blue Treasure Pharmaceuticals Co. Ltd. - March 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/guangdong-blue-treasure-pharmaceuticals-co-ltd/f3fd3e21-9427-416d-a156-063eb8271453
Source feed: FDA_Inspections

> FDA Inspection 1235775 for Guangdong Blue Treasure Pharmaceuticals Co. Ltd. on March 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235775
- Company Name: Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
- Inspection Date: 2024-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 967404 - 2016-04-15](https://www.keypedia.com/records/fda_inspections/guangdong-blue-treasure-pharmaceuticals-co-ltd/03127235-d51e-4944-8449-434d713376a8)
- [FDA Inspection 849844 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/guangdong-blue-treasure-pharmaceuticals-co-ltd/3371439f-85f8-4765-ad68-90269aca18b7)
- [FDA Inspection 604387 - 2009-07-21](https://www.keypedia.com/records/fda_inspections/guangdong-blue-treasure-pharmaceuticals-co-ltd/06b85f5d-d8df-4172-92b2-d732f73b4e94)

Company: https://www.keypedia.com/companies/guangdong-blue-treasure-pharmaceuticals-co-ltd/f8ccf2ed-b582-488a-b782-cb8511ce5453

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c